Veterinary Medicine Teaching and Research Center, University of California-Davis, Tulare, CA 93274, USA.
J Dairy Sci. 2009 Nov;92(11):5436-46. doi: 10.3168/jds.2009-2134.
The objectives were to evaluate the effect of supplemental progesterone during a timed artificial insemination (TAI) protocol on pregnancy per insemination and pregnancy loss. Lactating dairy cows from 2 dairy herds were presynchronized with 2 injections of PGF(2alpha) 14 d apart, and cows observed in estrus following the second PGF(2alpha) injection were inseminated (n = 1,301). Cows not inseminated by 11 d after the end of the presynchronization were submitted to the TAI protocol (d 0 GnRH, d 7 PGF(2alpha), d 8 estradiol cypionate, and d 10 TAI). On the day of the GnRH of the TAI protocol (study d 0), cows were assigned randomly to receive no exogenous progesterone (control = 432), one controlled internal drug-release (CIDR) insert (CIDR1 = 440), or 2 CIDR inserts (CIDR2 = 440) containing 1.38 g of progesterone each from study d 0 to 7. Blood was sampled on study d 0 before insertion of CIDR for determination of progesterone concentration in plasma, and cows with concentration <1.0 ng/mL were classified as low progesterone (LP) and those with concentration > or =1.0 ng/mL were classified as high progesterone (HP). From a subgroup of 240 cows, blood was sampled on study d 3, 7, 17 and 24 and ovaries were examined by ultrasonography on study d 0 and 7. Pregnancy was diagnosed at 38 +/- 3 and 66 +/- 3 d after AI. Data were analyzed including only cows randomly assigned to treatments and excluding cows that were inseminated after the second PGF(2alpha) injection. The proportion of cows classified as HP at the beginning of the TAI protocol was similar among treatments, but differed between herds. Concentrations of progesterone in plasma during the TAI protocol increased linearly with number of CIDR used, and the increment was 0.9 ng/mL per CIDR. The proportion of cows with plasma progesterone > or =1.0 ng/mL on study d 17 was not affected by treatment, but a greater proportion of control than CIDR-treated cows had asynchronous estrous cycles following the TAI protocol. Treatment with CIDR inserts, however, did not affect pregnancy at 38 +/- 3 and 66 +/- 3 d after AI or pregnancy loss.
目的是评估在定时人工授精(TAI)方案中补充孕酮对每授精妊娠率和妊娠损失的影响。来自 2 个奶牛场的泌乳奶牛接受了 2 次 PGF(2alpha)注射的同期化处理,第 2 次 PGF(2alpha)注射后观察到发情的奶牛进行授精(n = 1,301)。在同期化处理结束后 11 天内未授精的奶牛被提交到 TAI 方案(d 0 GnRH,d 7 PGF(2alpha),d 8 雌二醇 Cypionate,d 10 TAI)。在 TAI 方案的 GnRH 日(研究 d 0),奶牛被随机分配接受无外源性孕酮(对照组 = 432)、1 个控释内部药物释放(CIDR)插塞(CIDR1 = 440)或 2 个 CIDR 插塞(CIDR2 = 440),每个 CIDR 插塞含有 1.38 g 孕酮,从研究 d 0 到 7 天。在插入 CIDR 之前,在研究 d 0 时采集血样以测定血浆中的孕酮浓度,浓度<1.0 ng/mL 的奶牛被归类为低孕酮(LP),浓度≥1.0 ng/mL 的奶牛被归类为高孕酮(HP)。从 240 头奶牛的亚组中,在研究 d 3、7、17 和 24 时采集血样,并在研究 d 0 和 7 时通过超声检查卵巢。在 AI 后 38 +/- 3 和 66 +/- 3 天诊断妊娠。仅包括随机分配到处理组的奶牛的数据进行分析,不包括在第二次 PGF(2alpha)注射后授精的奶牛。在 TAI 方案开始时,被归类为 HP 的奶牛比例在处理组之间相似,但在牛群之间不同。在 TAI 方案期间,血浆孕酮浓度随 CIDR 使用数量呈线性增加,每个 CIDR 增加 0.9 ng/mL。在研究 d 17 时,有≥1.0 ng/mL 孕酮的奶牛比例不受处理的影响,但与 CIDR 处理的奶牛相比,对照组中发情周期不同步的奶牛比例更高。然而,CIDR 插塞的处理并未影响 AI 后 38 +/- 3 和 66 +/- 3 天的妊娠或妊娠损失。